Suzanne Fuqua on the Interaction Between ER and AR

Suzanne A. W. Fuqua, PhD
Published: Thursday, Sep 12, 2013

Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, talks about the interaction between estrogen receptors (ER) and androgen receptors (AR) in patients with breast cancer.

Fuqua says receptors, like AR and ER, can bind together at non-genomic sites and elicit one effect, like protein kinase B/Akt. Receptors can also bind together on DNA to help regulate genes, which cause proliferation, Fuqua says.

The basic biology is becoming clear that receptors are acting together, Fuqua says, raising the need for combination therapies when treating patients with breast cancer.

Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, talks about the interaction between estrogen receptors (ER) and androgen receptors (AR) in patients with breast cancer.

Fuqua says receptors, like AR and ER, can bind together at non-genomic sites and elicit one effect, like protein kinase B/Akt. Receptors can also bind together on DNA to help regulate genes, which cause proliferation, Fuqua says.

The basic biology is becoming clear that receptors are acting together, Fuqua says, raising the need for combination therapies when treating patients with breast cancer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x